Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhuhai Jinhong Pharmaceutical is a China-based pharmaceutical company that specializes in the research, development, and large-scale manufacturing of chemical drug preparations. Founded in 1992 and headquartered in Zhuhai, the company has built a significant reputation as a leading producer of cephalosporin antibiotics, including Cefixime and Cefdinir. Its product portfolio extends beyond anti-infectives to include treatments for cardiovascular diseases, metabolic disorders, and gastrointestinal conditions. The company operates advanced, GMP-certified manufacturing facilities designed for high-volume production of oral solid dosage forms. Jinhong Pharmaceutical is publicly traded on the National Equities Exchange and Quotations (NEEQ) in China. It continues to focus on the domestic market while maintaining a commitment to quality and technological innovation in drug formulation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhuhai Jinhong Pharmaceutical.